novo nordisk semaglutide clinical trials announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity FLOW clinical Trial (funded by

Muscle plays an important role in the following: Boosting metabolism: Muscle burns more calories than fat

will be in effect until Dec

According to the MHRA SmPC, semaglutide does not reduce the efficacy of hormonal contraceptives, though severe vomiting or diarrhoea may potentially affect the absorption of oral contraceptive pills, requiring temporary additional contraceptive measures

Our findings suggest that tirzepatide may ameliorate metabolic dysfunction by upregulating Tfrc expression, thereby contributing to improvements in obesity, insulin resistance, and inflammation

Attend all scheduled appointments and don't hesitate to contact your GP or diabetes nurse between visits if you experience: Severe or persistent nausea/vomiting preventing adequate nutrition or hydration Signs of pancreatitis (severe, persistent abdominal pain radiating to the back) Symptoms of gallbladder problems (right upper abdominal pain, particularly after eating) Unexplained visual changes Signs of hypoglycaemia if taking other diabetes medications Realistic goal-setting improves long-term success

What Concerns Can Semaglutide Address